In vitro (neuron–glia coculture) and in vivo (AD rat models) systems were used to evaluate the changes in the intracellular expression and localization of CX3CL1, as well as some transcription factors involved in its signaling cascade, including p38 and β catenin. The gene discussed is CX3CL1; the disease is Alzheimer disease.